Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs NEULAND LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA NEULAND LABS DISHMAN PHARMA/
NEULAND LABS
 
P/E (TTM) x 30.0 25.4 118.0% View Chart
P/BV x 3.3 8.1 41.3% View Chart
Dividend Yield % 0.7 0.2 417.3%  

Financials

 DISHMAN PHARMA   NEULAND LABS
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
NEULAND LABS
Mar-23
DISHMAN PHARMA/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs3742,004 18.7%   
Low Rs129966 13.3%   
Sales per share (Unadj.) Rs197.0928.4 21.2%  
Earnings per share (Unadj.) Rs21.2127.4 16.6%  
Cash flow per share (Unadj.) Rs34.7168.6 20.6%  
Dividends per share (Unadj.) Rs2.0010.00 20.0%  
Avg Dividend yield %0.80.7 118.0%  
Book value per share (Unadj.) Rs179.9774.8 23.2%  
Shares outstanding (eoy) m80.7012.83 629.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.6 79.9%   
Avg P/E ratio x11.911.7 101.9%  
P/CF ratio (eoy) x7.38.8 82.3%  
Price / Book Value ratio x1.41.9 73.0%  
Dividend payout %9.47.8 120.3%   
Avg Mkt Cap Rs m20,30719,052 106.6%   
No. of employees `000NANA-   
Total wages/salary Rs m5,3552,018 265.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,89811,912 133.5%  
Other income Rs m26597 272.3%   
Total revenues Rs m16,16312,009 134.6%   
Gross profit Rs m4,1032,718 150.9%  
Depreciation Rs m1,091528 206.6%   
Interest Rs m944131 722.7%   
Profit before tax Rs m2,3342,157 108.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624522 119.4%   
Profit after tax Rs m1,7101,635 104.6%  
Gross profit margin %25.822.8 113.1%  
Effective tax rate %26.724.2 110.4%   
Net profit margin %10.813.7 78.4%  
BALANCE SHEET DATA
Current assets Rs m11,0187,609 144.8%   
Current liabilities Rs m9,5174,390 216.8%   
Net working cap to sales %9.427.0 34.9%  
Current ratio x1.21.7 66.8%  
Inventory Days Days576 896.0%  
Debtors Days Days31,109 0.3%  
Net fixed assets Rs m18,7878,189 229.4%   
Share capital Rs m161129 125.1%   
"Free" reserves Rs m14,3549,812 146.3%   
Net worth Rs m14,5169,941 146.0%   
Long term debt Rs m4,189742 564.3%   
Total assets Rs m29,80515,798 188.7%  
Interest coverage x3.517.5 19.8%   
Debt to equity ratio x0.30.1 386.4%  
Sales to assets ratio x0.50.8 70.7%   
Return on assets %8.911.2 79.7%  
Return on equity %11.816.4 71.6%  
Return on capital %17.521.4 81.8%  
Exports to sales %24.973.5 33.9%   
Imports to sales %3.715.1 24.7%   
Exports (fob) Rs m3,9568,750 45.2%   
Imports (cif) Rs m5941,804 32.9%   
Fx inflow Rs m4,9528,750 56.6%   
Fx outflow Rs m6971,804 38.6%   
Net fx Rs m4,2556,946 61.3%   
CASH FLOW
From Operations Rs m2,7862,372 117.5%  
From Investments Rs m-1,529-615 248.6%  
From Financial Activity Rs m-941-1,358 69.3%  
Net Cashflow Rs m317403 78.5%  

Share Holding

Indian Promoters % 61.4 32.8 187.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 29.1 78.8%  
FIIs % 12.0 22.7 52.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 67.2 57.4%  
Shareholders   52,291 27,723 188.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs NEULAND LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs NEULAND LABS Share Price Performance

Period Dishman Pharma NEULAND LABS S&P BSE HEALTHCARE
1-Day 2.87% -1.12% 1.18%
1-Month -2.45% -11.56% -0.75%
1-Year 96.38% 269.91% 61.82%
3-Year CAGR 89.34% 43.81% 18.16%
5-Year CAGR 38.20% 59.26% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the NEULAND LABS share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of NEULAND LABS the stake stands at 32.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of NEULAND LABS.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

NEULAND LABS paid Rs 10.0, and its dividend payout ratio stood at 7.8%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of NEULAND LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.